Interstitial Lung Disease for the PCP Jeff Swigris, DO, MS Associate Professor of Medicine Interstitial Lung Disease Program National Jewish Health Denver,

Slides:



Advertisements
Similar presentations
HRCT of Common Lung Diseases W. Richard Webb MD. Common Lung Diseases: HRCT Infections (pneumonia, airways disease) Infections (pneumonia, airways disease)
Advertisements

High-Resolution Lung CT: Key Findings and What They Mean W
Interstitial Lung Disease (ILD) Mike McFarlane (CT1) 12/5/12 SLIME.
Pulmonology Case Presentation
Interstitial lung disease
Diagnostic tools – imaging and lung function (humans)
Interstitial Lung Disease -associations with autoantibodies Dr Felix Woodhead Locum Respiratory Physician UHCW 5 October 2010.
Coinvolgimento polmonare nella sclerosi sistemica Marco Matucci Cerinic Departments of Rheumatology AVC BioMedicine & Division of Rheumatology AOUC Medicine,
Case of combined pulmonary fibrosis with emphysema(CPFE) and its importance to recognize Abstract ID
FACULTY Title Affiliation
©2014 MFMER | slide-1 Collagen Vascular Diseases and the Lung Clinical Aspects Robert Vassallo, MD Mayo Clinic, Rochester, MN, USA. Pneumotrieste congress.
1 Restrictive and Interstitial Lung Disease J.B. Handler, M.D. Physician Assistant Program University of New England.
Dyspnea and Rash Andres Quiceno, MD Rheumatology PHD.
Radiology of Connective Tissue Disease associated Interstitial Lung Disease John Murchison.
LUNG FUNCTION IN HEALTH AND DISEASE: SPIROMETRY Sultan Ayoub Meo MBBS, PGC Med Ed, PG Dip Med Ed, M.Phil, Ph.D Professor, Department of Physiology, College.
ILDs Wael Batobara. Interstitial Lung Diseases It is a group of diseases that shares the same clinical & radiological presentations Prognosis depends.
Interstitial Lung Disease
RESTRICTIVE LUNG DISEASE
INTERSTITIAL LUNG DISEASE
Idiopathic Pulmonary Fibrosis (IPF) How we could do better Dr. D. K. Pillai Wednesday, 13 th August 2014 Medical Update Group at UoM.
IDIOPATHIC PULMONARY FIBROSIS
THE DIAGNOSIS OF IPF Steven A. Sahn, MD
IDIOPATHIC PULMONARY FIBROSIS
Interstital Lung Disease
Hypersensitivity Pneumonitis
Pulmonary Fibrosis and Gradual Onset Breathlessness Dr. Tim Sutherland Consultant with a specialist interest in ILD.
PULMONARY FIBROSIS.
Introduction to Pulmonary Medicine
IDIOPATHIC PULMONARY FIBROSIS. BASICS in IPF CLASSIFICATION OF INTERSTITIAL LUNG DISEASE OR DIFFUSE PARENCHYMAL LUNG DISEASE.
NYU Medical Grand Rounds Clinical Vignette Lucy Doyle MD, PGY-2 March 24, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Interstitial Lung Disease MODULE G4 Chapter 28: pp
Esam H. Alhamad, M.D Assistant Professor of Medicine Consultant Pulmonary & Critical Care Medicine.
LUNG FUNCTIONS IN HEALTH AND DISEASE Prof. Sultan Ayoub Meo MBBS, M.Phil, Ph.D (Pak), PG Dip Med Ed (Scotland) FRCP (London), FRCP (Dublin), FRCP (Glasgow),
History : 52-year-old male presented with a left testicular mass. An initial chest radiograph was performed, followed by a CT. Question : What are the.
PFF Teal = MAIN COLORS PFF Green = Light Green = Red = HIGHLIGHT COLORS Light Grey = Dark Grey =
Chronic Interstitial (Restrictive, Infiltrative) Lung Diseases
Restrictive lung disease
Interstitial Lung Diseases Pulmonary Medicine Department Ain Shams University
Chronic dyspnea of pulmonary origin
RHEUMATOID ARTHRITIS (RA). Introduction RA is a chronic, systemic inflammatory disorder of unknown etiology characterized by the manner in which it involved.
Clinical Tools for the Primary Care Physician. Objectives Raise the clinical index of suspicion for ILD in patients presenting with the hallmark signs.
Kevin O. Leslie, MD, Mayo Clinic, Scottsdale, Arizona
Interstitial lung disease
Usual interstitial pneumonia: an overview Ola El-Zammar, M.D. Assistant professor of pathology SUNY Upstate Medical University, Syracuse, NY.
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Demystifying Idiopathic Interstitial Pneumonia Arch.
Emerging Approaches to Treatment of IPF Gregory P. Cosgrove, MD Associate Professor, Pulmonary Division Assistant Director, Interstitial Lung Disease Program.
Interstitial Lung Disease TUCOM Internal Medicine 4th class Dr. Hasan
Bachar Samra MD1, Jacques Azzi MD1, Ambreen Khalil MD2.
Diseases of the respiratory system lecture 5
Lung function in health and disease
Recent Advances in Idiopathic Pulmonary Fibrosis
Patient with IPF and no honeycombing on HRCT
Diagnostic Approach to the Patient With Diffuse Lung Disease
Idiopathic Pulmonary Fibrosis: Current Concepts
831_ePAT CARE: Patient case Dr. Molina Dr
Patient with IPF and concomitant emphysema
Respiratory MCNs - Interstitial lung diseases
Patient Demographics Referred by:
Name: Age: Sex: Presenting History Symptom progression Current status:
Trials and the Tyranny of Arbitrary Cut-offs in Idiopathic Pulmonary Fibrosis David thickett 11 July 2014.
Patient with FVC>90% predicted
Chapter 24 Interstitial Lung Disease
Non-specific Interstitial Pneumonia What is it? Who knows?
Interstitial lung disease
Rheumatoid Arthritis-Associated Interstitial Lung Disease
3º Curso de Doenças Pulmonares Difusas – FMUP/HSJ
How is pulmonary fibrosis diagnosed and monitored?
Procedure for the diagnosis of interstitial lung diseases.
Presentation transcript:

Interstitial Lung Disease for the PCP Jeff Swigris, DO, MS Associate Professor of Medicine Interstitial Lung Disease Program National Jewish Health Denver, Colorado

Objectives  Define the interstitium  Define ILD  Finding the cause  Clinical presentation  Therapy  Define internist’s role

Where is the interstitium?

170, ,000 alveoli in here ~1-1.5cm

Classification based on etiology ILD Exposure-related mold, bacteria, birds medications XRT dusts cigarette smoke Idiopathic Sarcoidosis IIP Genetic FPF CTD-related RA Systemic sclerosis PM/DM Sjögren’s syndrome MCTD UCTD SLE

DAD DIP OP RB-ILD CFA IPF BOOP COP LIP NSIP UIP AIP Hamman-Rich BO HP UIPOB

Idiopathic interstitial pneumonias (IIP)  Idiopathic pulmonary fibrosis (IPF)  Nonspecific interstitial pneumonia (NSIP)  Cryptogenic organizing pneumonia (COP)  (Idiopathic BOOP)  Acute interstitial pneumonia (AIP)  Desquamative interstitial pneumonia (DIP)  Respiratory bronchiolitis-ILD (RB-ILD)  Lymphoid interstitial pneumonia (LIP)

Classification based on histology

ILD Exposure-related mold, bacteria, birds medications XRT dusts cigarette smoke Idiopathic Sarcoidosis LAM IIP Genetic FPF Autoimmune-related RA Systemic sclerosis PM/DM Sjögren’s syndrome MCTD

Nicholson et al. Am J Respir Crit Care Med 2000;162: Scar = bad prognosis Fibrosis Inflammation

What type of fibrosis is the PCP most likely to see?  ++++ Idiopathic pulmonary fibrosis (IPF)  Aging population  ++++ Connective tissue disease-related  RA  + Chronic hypersensitivity pneumonitis  Organic exposure (M/M/B/B

Making the diagnosis You have to be a detective  History  Exam  Pulmonary physiology  Radiography  +/- surgical lung biopsy

History: chief complaint  Typically, ILD presents with:  Dyspnea—subacute, insidious onset  “I thought I was just…”  Getting older  5# heavier  Out of shape  +/- dry cough  Fatigue  No wheeze, no chest pain

History History Be a good detective  Symptoms/existence of concurrent disease  Patients may…  1. Have known CTD  2. Dyspnea from occult CTD-related ILD  Family history  Pulmonary fibrosis  Rheumatologic illness

History: exposures History: exposures Be a good detective  Smoking PEARL  IPF  DIP, RB-ILD, PLCH  Goodpasture’s

History: exposures History: exposures Be a good detective  Current or previous medications   Chemotherapy  Amiodarone  Nitrofurantoin  External beam radiation  Current or previous recreational drug use  Occupational, environmental, avocational PEARL

History: exposures History: exposures Be a good detective  Microbial agents  M/M/B/B  Hot tubs (indoor/enclosed)  Basement shower  Free-standing humidifiers  Water damage to home  Cooling systems (swamp cooler)

History: exposures History: exposures Be a good detective  Birds (proteins)  Bloom on feathers  Mucin in excrement  Feather pillow/down comforter  Fumes, dusts, gases  Asbestos  Beryllium

History: connective tissue diseases  RA  Symmetric arthritis/small joints  Morning stiffness  Subcutaneous nodules  Smoker PEARL

History: connective tissue diseases  SSc  Raynauds  After 40 y.o. in FEMALE  After 30 y.o. in MALE  Esophageal dysmotility  Skin tightening PEARL

History: connective tissue diseases   Sjögren’s Syndrome  Dry eyes/mouth  Dental caries

History: connective tissue diseases  PM/DM  Proximal muscle weakness  Rashes  Rough skin on the hands

Physical Exam

Physical examination Physical examination You’re still a detective  Skin  Rash  Purupura  Telangiectasia  Nodules  Calcinosis

Physical examination  Nails  Clubbing  COPD no clubbing PEARL

Nailfold capillaroscopy Normal Abnormal Fischer et al. Chest. In press

Physical examination  Chest  Velcro crackles are NEVER normal Must listen here PEARL

Laboratory  ANA—the pattern matters  Nucleolar ANA any titer – TO RHEUM  SSA is a myositis associated ab (ANA -)  ACE level non-specific  Don’t order it  HP panels unhelpful  Precipitating IgG to organic antigens  Don’t order them PEARLS

Laboratory  Isolated high MCV  Methotrexate  Azathioprine  ??? Telomerase abnormality  Elevated MCV  History of bone marrow irregularities  Premature graying  Cryptogenic cirrhosis  Pulmonary fibrosis PEARLS

Pulmonary physiology  Pulmonary function testing  Gas exchange

Pulmonary function testing  Lung volumes  Spirometry  DLCO  ABG

Patients with ILD have Restrictive Physiology  Low static lung volumes  Low forced volumes  Low FVC  Low FEV1  Normal FEV1/FVC

Volumes may be normal if… + …but the DLCO will be very low

Impaired Gas Exchange  SpO2 at rest is unhelpful  Exercise oximetry  Never normal to desaturate  6-minute walk test PEARL

Radiology: diagnosing ILD  “ILD protocol” HRCT  No IV contrast  Supine and prone  Inspiratory and expiratory images  Reconstruction algorithm — 1-1.5mm thick

HRCT Terminology  Opacities  Lines (reticular)  Dots or Circles (nodules)  Patches  Attenuation (shade of gray)  Consolidation – obscures underlying vessels  Ground glass – does not obscure underlying vessels

Lower zone Peripheral/subpleural Reticular opacities Traction bronchiectasis Interlobular septal thickening

Honeycombing

Ground glass opacities

Lung biopsy  Transbronchial biopsy  Sarcoidosis  Lymphangitic carcinomatosis  Subacute HP  Surgical  Thorascopic  Usually not if CTD-related

Putting it all Together  History  Exam  Labs  ANA, RF, anti-CCP  Physiology  Full PFTs  Gas exchange  6MWT  Radiology  HRCT  Pathology Integrate to get “summary diagnosis”

Therapy for ILD  Not all patients require therapy  General: treat clinically significant, progressive dz  All therapeutic regimens require monitoring  Glucocorticoids may be the mainstay  Steroid-sparing / immune-suppressing / immunomodulatory / cytotoxic agents  Nuance

STABILITY = SUCCESS I don’t want my patients ILD leaving clinic thinking they don’t have a serious condition I don’t want my patients with ILD leaving clinic thinking they should go home, sit on their couch and die

Gauging Response  Q 3mos visits to pulm  Subjective  Symptoms  FVC  DLCO  6MWT  Not HRCT unless scenario mandates

Internist: before ILD dx  Thorough history and examination  Order HRCT  Order serologies  ANA with pattern and ENA panel  RF/anti-CCP  Order PFTs/6MWT/HRCT  Refer: ILD on HRCT

Internist: after ILD dx  Monitor for side effects of therapy  Glucocorticoids  Weight  Sugar  BP  Eyes  Bones  Be on the lookout for infection  Monitor need for oxygen  Communicate with patient  Mood: therapy needed?  End-of-life discussions

Internist: after ILD dx  Refer to pulmonary rehabilitation  Vaccines  Sunscreen for all on immunosuppressive Tx  Monthly labs for all on immunosuppressive Tx

Five Main Points  You will see ILD — be a detective  Velcro crackles never normal — get HRCT  Surgical lung biopsy often needed to make a confident diagnosis  All patients and most therapies require monitoring—the internist is vital here